High-dose regimens of hypomethylating agents promote transfusion independence in IPSS lower-risk myelodysplastic syndromes: a meta-analysis of prospective studies.

Wan, Ziqi; Han, Bing

Wan, Ziqi; Han, Bing.

Affiliation

Wan Z; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, China.
Han B; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, China.

Aging (Albany NY) ; 13(8): 11120-11134, 2021 03 26.

Article de En | MEDLINE | ID: mdl-33818418

Sujet(s)
Mots clés

azacytidine; decitabine; efficacy; lower-risk myelodysplastic syndromes; side effects

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transfusion sanguine / Syndromes myélodysplasiques / Antimétabolites antinéoplasiques Type d'étude: Etiology_studies / Observational_studies / Risk_factors_studies / Systematic_reviews Limites: Humans Langue: En Journal: Aging (Albany NY) Sujet du journal: GERIATRIA Année: 2021 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google